TransAct (TACT) Stock Forecast, Price Target & Predictions
TACT Stock Forecast
TransAct stock forecast is as follows: an average price target of $9.00 (represents a 113.27% upside from TACT’s last price of $4.22) and a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.
TACT Price Target
The average price target for TransAct (TACT) is $9.00 based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $9.00 to $9.00. This represents a potential 113.27% upside from TACT's last price of $4.22.
TACT Analyst Ratings
According to 1 Wall Street analysts, TransAct's rating consensus is 'Buy'. The analyst rating breakdown for TACT stock is 0 'Strong Buy' (0.00%), 1 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
TransAct Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Mar 13, 2024 | TransAct Technologies | Craig-Hallum | $9.00 | $5.88 | 53.06% | 113.27% |
The latest TransAct stock forecast, released on Mar 13, 2024 by TransAct Technologies from Craig-Hallum, set a price target of $9.00, which represents a 53.06% increase from the stock price at the time of the forecast ($5.88), and a 113.27% increase from TACT last price ($4.22).
TransAct Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 1 |
| Avg Price Target | - | - | $9.00 |
| Last Closing Price | $4.22 | $4.22 | $4.22 |
| Upside/Downside | -100.00% | -100.00% | 113.27% |
In the current month, the average price target of TransAct stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to TransAct's last price of $4.22. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Mar 13, 2024 | Craig-Hallum | Buy | Buy | Hold |
TransAct's last stock rating was published by Craig-Hallum on Mar 13, 2024. The company gave TACT a "Buy" rating, the same as its previous rate.
TransAct Financial Forecast
TransAct Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | $13.27M | $17.19M | $19.91M | $22.27M | $17.96M | $17.86M | - | $9.70M | $11.12M | $10.64M | $9.32M | $8.30M | $7.76M | $7.30M | $5.29M | $10.25M | $11.16M | $11.69M | $11.35M | $11.55M | $15.84M | $14.75M |
| Avg Forecast | $15.00M | $14.95M | $14.18M | $13.70M | $12.78M | $12.09M | $10.46M | $11.39M | $13.60M | $16.19M | $18.45M | $17.59M | $16.90M | $13.82M | $10.44M | $11.12M | $10.18M | $9.44M | $8.33M | $8.02M | $7.66M | $7.17M | $5.08M | $11.18M | $11.50M | $14.46M | $13.37M | $12.19M | $11.52M | $12.17M |
| High Forecast | $15.30M | $15.25M | $14.47M | $13.97M | $13.04M | $12.33M | $10.67M | $11.61M | $13.87M | $16.51M | $18.82M | $17.94M | $17.24M | $14.09M | $10.44M | $11.20M | $10.26M | $9.51M | $8.39M | $8.07M | $7.72M | $7.22M | $5.11M | $11.26M | $11.58M | $14.57M | $13.47M | $12.28M | $13.82M | $14.60M |
| Low Forecast | $14.70M | $14.66M | $13.90M | $13.43M | $12.53M | $11.85M | $10.25M | $11.16M | $13.33M | $15.87M | $18.08M | $17.24M | $16.56M | $13.54M | $10.44M | $11.04M | $10.11M | $9.37M | $8.27M | $7.96M | $7.61M | $7.12M | $5.04M | $11.10M | $11.41M | $14.36M | $13.27M | $12.10M | $9.21M | $9.74M |
| # Analysts | - | - | - | - | - | 1 | - | - | 1 | - | - | - | - | - | - | - | - | - | - | 4 | 6 | 4 | 6 | 4 | 5 | 3 | 5 | 3 | 8 | 19 |
| Surprise % | - | - | - | - | - | - | - | - | 0.98% | 1.06% | 1.08% | 1.27% | 1.06% | 1.29% | - | 0.87% | 1.09% | 1.13% | 1.12% | 1.04% | 1.01% | 1.02% | 1.04% | 0.92% | 0.97% | 0.81% | 0.85% | 0.95% | 1.38% | 1.21% |
TransAct's average Quarter revenue forecast for Mar 24 based on 0 analysts is $11.39M, with a low forecast of $11.16M, and a high forecast of $11.61M. TACT's average Quarter revenue forecast represents a -14.17% decrease compared to the company's last Quarter revenue of $13.27M (Dec 23).
TransAct EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | 1 | - | - | 1 | - | - | - | - | - | - | - | - | - | - | 4 | 6 | 4 | 6 | 4 | 5 | 3 | 5 | 3 | 8 | 19 |
| EBITDA | - | - | - | - | - | - | - | - | $-136.00K | $1.19M | $1.22M | $3.81M | $494.00K | $387.00K | - | $-5.18M | $-913.00K | $677.00K | $-2.58M | $-2.54M | $-1.98M | $-1.14M | $-2.54M | $-1.22M | $-269.00K | $500.00K | $403.00K | $1.12M | $3.41M | $1.78M |
| Avg Forecast | $-1.60M | $-1.60M | $-1.52M | $-1.46M | $-1.37M | $-1.29M | $-1.12M | $-3.72M | $-1.45M | $-1.73M | $-1.97M | $-3.38M | $-1.81M | $1.03M | $-1.11M | $-3.07M | $1.81M | $935.71K | $-2.78M | $-2.43M | $-818.58K | $-1.44M | $-542.20K | $-501.60K | $-1.23M | $-1.54M | $-1.43M | $-1.30M | $2.13M | $1.40M |
| High Forecast | $-1.57M | $-1.57M | $-1.48M | $-1.43M | $-1.34M | $-1.27M | $-1.10M | $-2.97M | $-1.42M | $-1.70M | $-1.93M | $-2.70M | $-1.77M | $1.24M | $-1.11M | $-2.46M | $2.17M | $1.12M | $-2.23M | $-1.94M | $-812.55K | $-1.15M | $-538.20K | $-401.28K | $-1.22M | $-1.53M | $-1.42M | $-1.29M | $2.56M | $1.68M |
| Low Forecast | $-1.63M | $-1.63M | $-1.55M | $-1.49M | $-1.39M | $-1.32M | $-1.14M | $-4.46M | $-1.48M | $-1.76M | $-2.01M | $-4.06M | $-1.84M | $823.42K | $-1.11M | $-3.69M | $1.45M | $748.57K | $-3.34M | $-2.92M | $-824.61K | $-1.73M | $-546.19K | $-601.92K | $-1.24M | $-1.56M | $-1.44M | $-1.31M | $1.71M | $1.12M |
| Surprise % | - | - | - | - | - | - | - | - | 0.09% | -0.69% | -0.62% | -1.13% | -0.27% | 0.38% | - | 1.68% | -0.50% | 0.72% | 0.93% | 1.04% | 2.42% | 0.79% | 4.69% | 2.42% | 0.22% | -0.32% | -0.28% | -0.86% | 1.60% | 1.27% |
1 analysts predict TACT's average Quarter EBITDA for Dec 23 to be $-1.45M, with a high of $-1.42M and a low of $-1.48M. This is -221.97% lower than TransAct's previous annual EBITDA (Sep 23) of $1.19M.
TransAct Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | 1 | - | - | 1 | - | - | - | - | - | - | - | - | - | - | 4 | 6 | 4 | 6 | 4 | 5 | 3 | 5 | 3 | 8 | 19 |
| Net Income | - | - | - | - | - | - | - | - | $-62.00K | $906.00K | $1.55M | $3.14M | $260.00K | $528.00K | - | $-4.01M | $-735.00K | $910.00K | $-2.11M | $-2.21M | $-1.92M | $-867.00K | $-1.85M | $-992.00K | $-800.00K | $384.00K | $186.00K | $746.00K | $2.57M | $1.21M |
| Avg Forecast | $-49.98K | $-249.93K | $-349.89K | $-399.88K | $-749.77K | $-799.76K | $-1.60M | $-3.24M | $-349.89K | $-99.97K | $649.80K | $-2.94M | $-49.98K | $1.38M | $-3.06M | $-2.67M | $-512.82K | $1.26M | $-2.28M | $-2.11M | $-1.34M | $-1.10M | $-3.39M | $-409.20K | $298.74K | $2.09M | $1.19M | $497.90K | $1.61M | $953.33K |
| High Forecast | $-48.70K | $-243.47K | $-340.87K | $-389.56K | $-730.43K | $-779.12K | $-1.56M | $-2.59M | $-340.87K | $-97.39K | $666.57K | $-2.35M | $-48.70K | $1.66M | $-3.06M | $-2.14M | $-410.26K | $1.51M | $-1.82M | $-1.69M | $-1.33M | $-878.56K | $-3.35M | $-327.36K | $301.60K | $2.11M | $1.21M | $502.66K | $1.93M | $1.14M |
| Low Forecast | $-51.27K | $-256.37K | $-358.92K | $-410.20K | $-769.12K | $-820.40K | $-1.64M | $-3.88M | $-358.92K | $-102.55K | $633.03K | $-3.53M | $-51.27K | $1.11M | $-3.06M | $-3.21M | $-615.38K | $1.01M | $-2.73M | $-2.54M | $-1.36M | $-1.32M | $-3.42M | $-491.04K | $295.88K | $2.07M | $1.18M | $493.13K | $1.29M | $762.67K |
| Surprise % | - | - | - | - | - | - | - | - | 0.18% | -9.06% | 2.38% | -1.07% | -5.20% | 0.38% | - | 1.50% | 1.43% | 0.72% | 0.93% | 1.04% | 1.43% | 0.79% | 0.55% | 2.42% | -2.68% | 0.18% | 0.16% | 1.50% | 1.60% | 1.27% |
TransAct's average Quarter net income forecast for Dec 23 is $-349.89K, with a range of $-358.92K to $-340.87K. TACT's average Quarter net income forecast represents a -138.62% decrease compared to the company's last Quarter net income of $906.00K (Sep 23).
TransAct SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | 1 | - | - | 1 | - | - | - | - | - | - | - | - | - | - | 4 | 6 | 4 | 6 | 4 | 5 | 3 | 5 | 3 | 8 | 19 |
| SG&A | - | - | - | - | - | - | - | - | $4.73M | $5.22M | $7.13M | $6.17M | $5.59M | $5.82M | - | $5.89M | $4.91M | $4.04M | $4.28M | $4.05M | $3.53M | $3.38M | $3.66M | $4.83M | $4.59M | $4.19M | $4.28M | $4.14M | $3.69M | $4.19M |
| Avg Forecast | $6.13M | $6.11M | $5.79M | $5.60M | $5.22M | $4.94M | $4.27M | $5.94M | $5.56M | $6.62M | $7.54M | $5.40M | $6.90M | $6.15M | $4.26M | $4.91M | $4.16M | $5.59M | $4.60M | $3.88M | $3.13M | $4.29M | $2.07M | $1.99M | $4.70M | $5.91M | $5.46M | $4.98M | $2.30M | $3.30M |
| High Forecast | $6.25M | $6.23M | $5.91M | $5.71M | $5.33M | $5.04M | $4.36M | $7.13M | $5.67M | $6.75M | $7.69M | $6.48M | $7.04M | $7.38M | $4.26M | $5.89M | $4.19M | $6.71M | $5.53M | $4.66M | $3.15M | $5.14M | $2.09M | $2.39M | $4.73M | $5.95M | $5.50M | $5.02M | $2.76M | $3.96M |
| Low Forecast | $6.01M | $5.99M | $5.68M | $5.49M | $5.12M | $4.84M | $4.19M | $4.76M | $5.45M | $6.48M | $7.39M | $4.32M | $6.77M | $4.92M | $4.26M | $3.93M | $4.13M | $4.47M | $3.68M | $3.11M | $3.11M | $3.43M | $2.06M | $1.59M | $4.66M | $5.87M | $5.42M | $4.94M | $1.84M | $2.64M |
| Surprise % | - | - | - | - | - | - | - | - | 0.85% | 0.79% | 0.95% | 1.14% | 0.81% | 0.95% | - | 1.20% | 1.18% | 0.72% | 0.93% | 1.04% | 1.13% | 0.79% | 1.77% | 2.42% | 0.98% | 0.71% | 0.78% | 0.83% | 1.60% | 1.27% |
TransAct's average Quarter SG&A projection for Mar 24 is $5.94M, based on 0 Wall Street analysts, with a range of $4.76M to $7.13M. The forecast indicates a 25.55% rise compared to TACT last annual SG&A of $4.73M (Dec 23).
TransAct EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | 1 | - | - | 1 | - | - | - | - | - | - | - | - | - | - | 4 | 6 | 4 | 6 | 4 | 5 | 3 | 5 | 3 | 8 | 19 |
| EPS | - | - | - | - | - | - | - | - | $-0.01 | $0.09 | $0.16 | $0.32 | $0.03 | $0.05 | - | $-0.41 | $-0.07 | $0.10 | $-0.24 | $-0.25 | $-0.22 | $-0.11 | $-0.25 | $-0.13 | $-0.11 | $0.05 | $0.02 | $0.10 | $0.35 | $0.16 |
| Avg Forecast | $-0.01 | $-0.03 | $-0.04 | $-0.04 | $-0.07 | $-0.08 | $-0.16 | $-0.15 | $-0.04 | $-0.01 | $0.07 | $0.03 | $-0.01 | $-0.19 | $-0.31 | $-0.19 | $-0.22 | $-0.28 | $-0.26 | $-0.23 | $-0.14 | $-0.15 | $-0.34 | $-0.08 | $0.03 | $0.21 | $0.12 | $0.05 | $0.15 | $0.07 |
| High Forecast | $-0.00 | $-0.02 | $-0.03 | $-0.04 | $-0.07 | $-0.08 | $-0.16 | $-0.15 | $-0.03 | $-0.01 | $0.07 | $0.03 | $-0.00 | $-0.19 | $-0.31 | $-0.19 | $-0.22 | $-0.27 | $-0.25 | $-0.23 | $-0.13 | $-0.15 | $-0.34 | $-0.08 | $0.03 | $0.21 | $0.12 | $0.05 | $0.18 | $0.09 |
| Low Forecast | $-0.01 | $-0.03 | $-0.04 | $-0.04 | $-0.08 | $-0.08 | $-0.16 | $-0.15 | $-0.04 | $-0.01 | $0.06 | $0.03 | $-0.01 | $-0.19 | $-0.31 | $-0.19 | $-0.22 | $-0.28 | $-0.26 | $-0.23 | $-0.14 | $-0.15 | $-0.34 | $-0.08 | $0.03 | $0.21 | $0.12 | $0.05 | $0.12 | $0.06 |
| Surprise % | - | - | - | - | - | - | - | - | 0.18% | -9.00% | 2.46% | 10.67% | -6.00% | -0.26% | - | 2.13% | 0.34% | -0.36% | 0.94% | 1.09% | 1.63% | 0.73% | 0.74% | 1.63% | -3.67% | 0.24% | 0.17% | 2.00% | 2.33% | 2.29% |
According to 1 Wall Street analysts, TransAct's projected average Quarter EPS for Dec 23 is $-0.04, with a low estimate of $-0.04 and a high estimate of $-0.03. This represents a -138.89% decrease compared to TACT previous annual EPS of $0.09 (Sep 23).
TransAct Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| TACT | TransAct | $4.22 | $9.00 | 113.27% | Buy |
| FARO | FARO | $17.49 | $32.00 | 82.96% | Buy |
TACT Forecast FAQ
Is TransAct a good buy?
Yes, according to 1 Wall Street analysts, TransAct (TACT) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 100.00% of TACT's total ratings.
What is TACT's price target?
TransAct (TACT) average price target is $9 with a range of $9 to $9, implying a 113.27% from its last price of $4.22. The data is based on 1 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will TransAct stock go up soon?
According to Wall Street analysts' prediction for TACT stock, the company can go up by 113.27% (from the last price of $4.22 to the average price target of $9), up by 113.27% based on the highest stock price target, and up by 113.27% based on the lowest stock price target.
Can TransAct stock reach $6?
TACT's average twelve months analyst stock price target of $9 supports the claim that TransAct can reach $6 in the near future.
What are TransAct's analysts' financial forecasts?
TransAct's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $46.72M (high $47.65M, low $45.79M), average EBITDA is $-7.493M (high $-6.674M, low $-8.312M), average net income is $-6.385M (high $-5.657M, low $-7.113M), average SG&A $20.38M (high $21.86M, low $18.91M), and average EPS is $-0.465 (high $-0.453, low $-0.477). TACT's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $57.84M (high $58.99M, low $56.69M), average EBITDA is $-6.178M (high $-6.056M, low $-6.301M), average net income is $-1.05M (high $-1.023M, low $-1.077M), average SG&A $23.63M (high $24.1M, low $23.16M), and average EPS is $-0.105 (high $-0.102, low $-0.108).
Did the TACT's actual financial results beat the analysts' financial forecasts?
Based on TransAct's last annual report (Dec 2023), the company's revenue was $72.63M, beating the average analysts forecast of $65.83M by 10.33%. Apple's EBITDA was $5.71M, missing the average prediction of $-8.534M by -166.87%. The company's net income was $4.75M, missing the average estimation of $-2.742M by -273.17%. Apple's SG&A was $23.25M, missing the average forecast of $25.11M by -7.41%. Lastly, the company's EPS was $0.47, beating the average prediction of $0.05 by 840.00%. In terms of the last quarterly report (Dec 2023), TransAct's revenue was $13.26M, missing the average analysts' forecast of $13.6M by -2.46%. The company's EBITDA was $-136K, missing the average prediction of $-1.453M by -90.64%. TransAct's net income was $-62K, missing the average estimation of $-350K by -82.28%. The company's SG&A was $4.73M, missing the average forecast of $5.56M by -14.80%. Lastly, the company's EPS was $-0.0062, missing the average prediction of $-0.035 by -82.29%